SEATTLE, WA--(Marketwired - Aug 28, 2017) - CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, announces publication of an exclusive interview with CURE Pharmaceutical's (
CURE Pharmaceutical was founded by six individuals with experience in the pharmaceutical industry working with companies like Amgen Inc. and Merck & Co. Inc. With a focus on pediatrics and geriatrics, the company developed an oral thin film delivery system that it is used to address conditions ranging from cancer and its side effects to neurological diseases.
The oral thin film technology, known as CureFilm™, is a proprietary toolbox of polymers designed to enhance the bioavailability of active pharmaceutical ingredients - or APIs. The combination of encapsulation methods and permeation enhancers enables APIs to bypass first-pass metabolism and effectively enter the bloodstream. This puts more APIs into the bloodstream and widens the therapeutic index via fewer side effects in the liver and GI tract.
In addition to CureFilm™, the company has developed a vertically integrated operation capable of taking drugs from a pre-feasibility study all the way through manufacturing in a FDA-registered facility that's compliant with cGMP standards.
CURE's current focus is on harnessing the potential of cannabinoids and terpenes to treat many underlying medical conditions, including cancer where it may cause apoptosis of cancer cells. Cannabinoids have also demonstrated strong potential in treating neurological conditions like Multiple Sclerosis, ALS, and Parkinson's disease, while improving cancer-related symptoms like pain, nausea, and appetite suppression.
Please follow the link to see the interview: http://www.cannabisfn.com/exclusive-interview-cure-pharma-discusses-vision-breakthrough-technology/
For more information, visit the company's website at www.curepharmaceutical.com.
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.